This is a snippet of the transcript, sign up to read more.
Because TransDigm was leveraging Boeing by saying hey, you're jerking us around over here, you didn't award us something or you're bad-mouthing us. Whatever you're doing, we're not going to renew the contract with Aviall and take away $50 million worth of revenue just like that. No discussion, no nothing, and Aviall was powerless to do anything about it.
This is a snippet of the transcript, sign up to read more.
Yes, that was part of this initial conversation. Where the idea came from of this specific battery was Boeing had said we need to take TransDigm out of the picture. So, being an engineering company, their idea was let's reverse engineer TransDigm parts. They had this project called Insourcing, which came to be named something else later. Let's identify these egregiously priced TransDigm parts, and we will make a Boeing version that we can offer the customer at a lower price.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research